Live market news
Stocks
CSTL

Castle Biosciences Inc.

CSTLStockUnited States

See in Charts

Latest news on CSTLranked by Oyticker for market impact

62Impact
Positive1 Oct 2026 · 01:16 UTC · Global · Medium term
CSTL presents late-breaking EADV 2026 data on DecisionDx-Melanoma clinical utility in SLNB decision-making
Castle Biosciences will present new clinical data at EADV 2026 supporting DecisionDx-Melanoma's role in sentinel lymph node biopsy (SLNB) decision-making and risk-stratified post-surgical management in melanoma patients.
CSTLDiagnosticsHealthcare ServicesOncology

SEC filings

What CSTL filed

All its filings

5 Nov 2026
Quarterly report (opens the document on sec.gov)10-Q
5 Nov 2026
Results announced (opens the document on sec.gov)8-K
Investor communication
30 Jul 2026
Quarterly report (opens the document on sec.gov)10-Q
30 Jul 2026
Results announced (opens the document on sec.gov)8-K
Investor communication
29 May 2026
Shareholder vote results (opens the document on sec.gov)8-K

From SEC EDGAR, the public record of what US-listed companies file. Each document opens on sec.gov.

Oyticker provides market information and analysis for educational purposes. It is not investment advice: you remain responsible for your own decisions.

Latest news on CSTLranked by Oyticker for market impact

CSTL presents late-breaking EADV 2026 data on DecisionDx-Melanoma clinical utility in SLNB decision-making

What CSTL filed